Blood test may end need for risky vein sampling in adrenal hypertension

NCT ID NCT07297745

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study tests whether measuring certain hormones in a blood sample can accurately identify which patients with primary aldosteronism (a common cause of high blood pressure) have a curable adrenal tumor. Currently, diagnosis often requires an invasive procedure called adrenal vein sampling. If the blood test works, it could simplify diagnosis, reduce risks, and help more people get the right treatment. The trial will enroll 120 adults who are willing to undergo both the blood test and standard procedures to compare accuracy.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance

blood test for hybrid hormones (18-oxocortisol, 18-hydroxycortisol)

What this could lead to

If successful, this could make diagnosing curable adrenal-related high blood pressure faster, cheaper, and less invasive for patients worldwide.

What could go wrong

This is an early-stage diagnostic study with only 120 participants. The blood test may not be accurate enough to replace current invasive methods, and results may not apply to all patient groups.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for PRIMARY ALDOSTERONISM DUE TO ALDOSTERONE PRODUCING ADENOMA are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

aldosterone-producing adrenal cortex adenoma hyperaldosteronism primary aldosteronism

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

More trials for these conditions

Other studies related to the condition(s) this trial covers.

Contacts and locations

Study contacts

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

Locations

  • Changi General Hospital

    Singapore, Singapore, 529889, Singapore

    Contact Phone: •••-•••-•••• Email: •••••@•••••

    Contact

  • National University Hospital

    Singapore, Singapore

    Contact Phone: •••-•••-•••• Email: •••••@•••••

  • Sengkang General Hospital

    Singapore, Singapore

    Contact Phone: •••-•••-•••• Email: •••••@•••••

  • Singapore General Hospital

    Singapore, Singapore

    Contact Phone: •••-•••-•••• Email: •••••@•••••